Vitamin D Deficiency and PAD: A Close and Often Overlooked Relationship  by Kapoor, S.
CORRESPONDENCEVitamin D Deﬁciency and PAD: A Close and Often
Overlooked Relationship
I read with great interest the recent article by Mazur et al.1
A number of vitamin deﬁciencies besides vitamin B12
deﬁciency may contribute to PAD.
Vitamin D deﬁciency is an independent risk factor for the
development and progression of PAD. Individuals with lower
serumvitaminDaremoreprone todevelop PAD. Similarly, one
third of the increased riskof PAD inAfro-American populations
in comparison to Caucasian populations is explained by the
lower vitamin D status observed in Afro-American pop-
ulations. Not surprisingly, secondary hyperparathyroidism is
relatively more common in patients with PAD. Higher ampu-
tation rates have been noticed in individuals with lower serum
vitamin D in the scenario of underlying PAD.2
Nearly 14% of patients with PAD demonstrate vitamin C
levels less than 11.4 mmol/l.3 In fact, a shorter absolute
claudication distance is seen in those with low L-ascorbic
acid concentration and underlying PAD.
The above examples clearly illustrate the importance of
vitamin supplementation in patients with PAD and the need
to increase awareness about this amongst physicians as well
as patients.
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Vitamins and Homocysteine Metabolism
We thank Dr. Kapoor for his interest in our recent article1 and
comments on potential links between vitamin D and
peripheral artery disease (PAD). Metabolism of homocysteine
(Hcy), derived from dietary methionine (Met), is regulated by
transsulfuration to cysteine, catalyzed by vitamin B6 depen-
dent cystathionine b-synthase (CBS), and remethylation to
Met, catalyzed by vitamin B12 and 5,10-methylenetetrahy-
drofolate dependent Met synthase (MS).2 Deﬁciency in
vitamin B12, vitamin B6 or folate is associated with increased
plasma total Hcy (tHcy), but it is still unknown to what extent
reduced vitamin cofactors alter N 3ehomocysteinylelysine
(N 3eHcyeLys), a degradation product of homocysteinylated
proteins. We reported that in PAD patients successfully
treated for hyperhomocysteinemia, N 3eHcyeLys is still
associatedwith disease progression and higher risk of adverse
cardiovascular events.1 Moreover, high intake of vitamins C
and E and carotenes is associated with lower tHcy.3
Interestingly, Kapoor pointed to a role of vitamin D
deﬁciency in PAD in the context of hyperhomocysteinemia.
An in vitro study revealed a link between Hcy metabolism
and vitamin D, which was conﬁrmed by the Longitudinal
Aging Study Amsterdam.4 Of note, vitamin D deﬁciency has
been reported to be accompanied by higher plasma asym-
metric dimethylarginine (ADMA) concentrations, which also
correlate positively with circulating N 3eHcyeLys.5,6 To our
knowledge, there have been no reports showing any asso-
ciation of vitamin D with N 3eHcyeLys. It might be specu-
lated that deﬁciency in vitamin D contributes to PAD
progression in part via disturbed Hcy metabolism.
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